| Title | Author(s) | Year | View Count |
 | A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma | Yau, T; Cheng, PN; Chan, P; Chan, W; Chen, L; Yuen, J; Pang, R; Fan, ST; Poon, RT | 2012 | 95 |
 | Overcoming obstacles associated with other learning experiences and school-based assessment: Perspectives of high school students with visual impairment in Hong Kong - Collaborative research project report | Yuen, MT; Ho, J; Chung, YB; Fong, RW; Cheng, S; Ho, JH; Kwok, D; Ho, S; Tsui, J; Chiu, CW; Cheng, CKY; Yuen, J; Cheung, V | 2012 | 93 |
 | A comprehensive HBV array for the detection of HBV mutants and genotype | Chan, K; Yam, I; Yuen, J; Yuen, MF; Lai, CL; Alexander, GJ; Chan, TK; Chan, V | 2011 | 186 |
 | Knowledge building international project: Designs for deep understanding | Laferrière, T; Perreault, C; Boutin, PA; Law, N; Yuen, J; Montané, M; Lopez, OH; Boluda, P; Blancafort, M | 2011 | 32 |
 | Automated data analysis to support teacher's knowledge building practice | Jing, L; Yuen, J; Wong, W; Law, N; Zhang, Y; Allaire, S; Perreault, C; Laferrière, T; Teplovs, C | 2011 | 37 |
 | Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment | Fung, J; Lai, CL; Young, J; Wong, DKH; Yuen, J; Seto, WK; Yuen, MF | 2011 | 249 |
 | Stability of hepatitis B surface antigen over time: Implications for studies using stored sera | Fung, J; Lai, CL; Young, J; Wong, DKH; Yuen, J; Seto, WK; Yuen, MF | 2011 | 151 |
 | Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy | Fung, J; Seto, WK; Lai, CL; Yuen, J; Wong, DKH; Yuen, MF | 2011 | 279 |
 | Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years | Fung, J; Lai, CL; Yuen, J; Cheng, C; Wu, R; KaHo Wong, D; Seto, WK; Hung, IFN; Yuen, MF | 2011 | 541 |
 | Natural history of chronic hepatitis C: Genotype 1 versus genotype 6 | Seto, WK; Lai, CL; Fung, J; Hung, I; Yuen, J; Young, J; Wong, DKH; Yuen, MF | 2010 | 3,020 |
 | Multivocality in visualization and interaction analysis: An exploration of the role of argumentation and questioning in knowledge building | Law, NWY; Lund, K; Yuen, J; Leng, J; Lu, J | 2009 | 94 |
 | The duration of lamivudine therapy for chronic hepatitis b: Cessation vs. continuation of treatment after HBeAg seroconversion | Fung, J; Lai, CL; Tanaka, Y; Mizokami, M; Yuen, J; Wong, DKH; Yuen, MF | 2009 | 51 |
 | Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma | Lam, VWT; Ng, KKC; Chok, KSH; Cheung, TT; Yuen, J; Tung, H; Tso, WK; Fan, ST; Poon, RTP | 2008 | 184 |
 | Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma | Ng, KK; Poon, RT; Lo, CM; Yuen, J; Tso, WK; Fan, ST | 2008 | 106 |
 | Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: Analysis of risk factors and prognostic factors | Lam, VWT; Ng, KK; Chok, KSH; Cheung, TT; Yuen, J; Tung, H; Tso, WK; Fan, ST; Poon, RTP | 2008 | 114 |
 | High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: Importance of tumor biomarker in ablative therapies | Poon, RTP; Lau, C; Pang, R; Ng, KK; Yuen, J; Fan, ST | 2007 | 163 |
 | Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma | Khan, MR; Poon, RTP; Ng, KK; Chan, AC; Yuen, J; Tung, H; Tsang, J; Sheung, TF | 2007 | 135 |
 | Duodenopleural fistula formation after percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma | Chan, FS; Ng, KK; Poon, RT; Yuen, J; Tso, WK; Fan, ST | 2007 | 44 |
 | A learnable content & participation analysis toolkit for assessing CSCL learning outcomes and processes | Law, N; Yuen, J; Huang, R; Li, Y; Pan, N | 2007 | 33 |
 | Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion | Ng, KK; Poon, RT; Lam, CM; Yuen, J; Tso, WK; Fan, ST | 2006 | 106 |
|